RecruitingNCT06487286
Levels of Visfatin/NAMPT in Human Milk
Levels of Visfatin/NAMPT in Human Milk.VISFAMILK
Sponsor
Paolo Manzoni Study Group
Enrollment
30 participants
Start Date
Oct 24, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.
Eligibility
Inclusion Criteria3
- Healthy male and female infants born after 37 weeks' gestation who do not have conditions related to congenital abnormalities
- Maternal hospitalization
- Acquisition of the informed consent form signed by the patient
Exclusion Criteria2
- Refusal of the patient to participate in the study
- Presence of hypogalactia or agalactia in the patient
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERobservational study
observational study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06487286
Related Trials
Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring
NCT051198682 locations
BEP Targeting Strategies in Ethiopia
NCT061258601 location
Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort
NCT065427181 location
Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia
NCT057081836 locations
Fresh RX: NHS 2020
NCT048452301 location